Science Huddle – Cell & Gene Therapy: Maximizing Commercialization
Enjoy an on-demand event featuring a world class line up of experts and scientific leaders discussing Cell & Gene Therapy: Maximizing Commercialization
With so many exciting advances – particularly in gene therapy now – coming out of the labs, developers need to maximize their commercialization potential through optimized planning.
Keith Thompson, CBE – Chairman of a Natural Killer (NK) cell therapy company, NK:IO, and advisor to Deep Science Ventures (Investors in Pharma).
Michael May – President & CEO of The Centre for Commercialization of Regenerative Medicine (CCRM)
Sven Kili – CEO at Antion Biosciences, a UK-based Multiplex Cell Engineering company
Dr Christian Schneider – Head of Biopharma Excellence and Chief Medical Officer, Biopharma Excellence